VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2017

Jun 5, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2017-06-01

Reporting Person: Silva Paul M (SVP & Corp Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-06-01	Common Stock	M	3867	$77.31	Acquired	23938	Direct
2017-06-01	Common Stock	S	3867	$127.31	Disposed	20071	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-06-01	Stock Option (Right to Buy)	$77.31	M	3867	Disposed	2024-02-04	Common Stock (3867)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	169	Indirect

Footnotes

F1: Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.

F2: The option vests in 16 quarterly installments from 02/05/2014.